SERA PROGNOSTICS, INC. (SERA) Current Ratio
- Current ratio · latest quarter: Value 1.98×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.98× | Current assets / current liabilities. $48.13M ÷ $24.36M ≈ 1.98× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 48.13M USD | Assets, Current |
| Current obligations | 24.36M USD | Liabilities, Current |
| Cash and equivalents | 4.40M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 42.05M USD | Marketable Securities, Current |
| Customer receivables | 10.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 1.19M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $48.13M | $24.36M | $4.40M | $42.05M | $10.00K | (m) | $1.19M | (m) | 1.98× |
| 2026-03-31 | $49.73M | $23.42M | $4.17M | $43.23M | $11.00K | (m) | $767.00K | (m) | 2.12× |
| 2025-12-31 | $40.77M | $24.19M | $3.94M | $35.26M | $12.00K | (m) | $862.00K | (m) | 1.69× |
| 2025-09-30 | $44.49M | $23.50M | $4.08M | $39.22M | $14.00K | (m) | $1.04M | (m) | 1.89× |
| 2025-06-30 | $40.87M | $23.60M | $5.02M | $35.14M | $17.00K | (m) | $1.06M | (m) | 1.73× |
| 2025-03-31 | $47.28M | $23.40M | $5.23M | $40.97M | $25.00K | (m) | $1.21M | (m) | 2.02× |
| 2024-12-31 | $47.60M | $24.77M | $4.04M | $42.19M | $34.00K | (m) | $1.97M | (m) | 1.92× |
| 2024-09-30 | $51.11M | $24.18M | $2.68M | $47.07M | $79.00K | (m) | $1.38M | (m) | 2.11× |
| 2024-06-30 | $51.54M | $24.76M | $4.66M | $46.28M | $101.00K | (m) | $952.00K | (m) | 2.08× |
| 2024-03-31 | $53.85M | $24.57M | $4.24M | $48.73M | $117.00K | (m) | $1.03M | (m) | 2.19× |
| 2023-12-31 | $61.34M | $24.44M | $3.88M | $45.20M | $160.00K | (m) | $1.05M | (m) | 2.51× |
| 2023-09-30 | $47.55M | $13.54M | $9.65M | $36.46M | $155.00K | (m) | $1.18M | (m) | 3.51× |
| 2023-06-30 | $64.43M | $14.18M | $32.28M | $31.54M | $163.00K | (m) | $1.24M | (m) | 4.54× |
| 2023-03-31 | $72.11M | $13.80M | $27.20M | $43.59M | $120.00K | (m) | $1.59M | (m) | 5.23× |
| 2022-12-31 | $90.13M | $15.54M | $29.88M | $52.83M | $113.00K | (m) | $1.55M | (m) | 5.80× |
| 2022-09-30 | $90.84M | $8.67M | $38.81M | $49.97M | $107.00K | (m) | $1.09M | (m) | 10.48× |
| 2022-06-30 | $108.05M | $7.30M | $53.89M | $53.02M | $73.00K | (m) | $783.00K | (m) | 14.80× |
| 2022-03-31 | $109.47M | $6.94M | $64.08M | $43.47M | $39.00K | (m) | $945.00K | (m) | 15.76× |
| 2021-12-31 | $110.25M | $8.41M | $58.93M | $46.18M | $27.00K | (m) | $1.20M | (m) | 13.11× |
| 2021-09-30 | $122.34M | $3.54M | $82.48M | $37.50M | $35.00K | (m) | $1.27M | (m) | 34.53× |
| 2021-06-30 | $91.37M | $3.23M | $90.85M | (m) | $14.00K | (m) | $1.03M | (m) | 28.27× |
| 2020-12-31 | $13.73M | $11.24M | $13.53M | $0.00 | $2.00K | (m) | $441.00K | (m) | 1.22× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |